Compare THR & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | THR | VIR |
|---|---|---|
| Founded | 1954 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2011 | 2019 |
| Metric | THR | VIR |
|---|---|---|
| Price | $52.55 | $9.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $54.00 | $19.63 |
| AVG Volume (30 Days) | 355.2K | ★ 2.1M |
| Earning Date | 05-21-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 3.97 | ★ 17.49 |
| EPS | ★ 1.27 | N/A |
| Revenue | ★ $276,181,000.00 | $68,556,000.00 |
| Revenue This Year | $6.08 | N/A |
| Revenue Next Year | $5.95 | $1,049.62 |
| P/E Ratio | $39.31 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $23.86 | $4.16 |
| 52 Week High | $58.56 | $10.91 |
| Indicator | THR | VIR |
|---|---|---|
| Relative Strength Index (RSI) | 58.64 | 59.08 |
| Support Level | $48.31 | $8.47 |
| Resistance Level | $53.25 | $10.29 |
| Average True Range (ATR) | 2.14 | 0.45 |
| MACD | 0.15 | -0.01 |
| Stochastic Oscillator | 87.22 | 87.54 |
Thermon Group Holdings Inc is a United States-based company that provides engineered industrial process heating solutions for process industries. It offers a full suite of products (heating units, electrode and gas-fired boilers, heating cables, industrial heating blankets and related products, temporary power solutions and tubing bundles), services (engineering, installation and maintenance services) and software (design optimization and wireless and network control systems) required to deliver comprehensive solutions to some of the world's Large and most complex projects. Its products and services include a wide range of electric heat tracing cables, steam heating solutions, controls, monitoring and software, instrumentation, project services, industrial heating and filtration solutions.
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.